TABLE 1.
Strain | Relevant genotype or phenotype | Source or reference |
---|---|---|
PS482a | ΔsspA ΔsspB ΔsspE Cmrb (α−β−γ−) | 9 |
PS832a | Wild-type derivative of strain 168 | Laboratory stock |
PY79c | Wild type | 47 |
IB464a | sspG::sspG-lacZ Cmr | pIB454→PS832 |
IB465a | sspJ::sspJ-lacZ Cmr | pIB452→PS832 |
IB488a | ΔsspG-yurS::spc Spr d | This work |
IB490a | ΔsspJ::spc Spr | This work |
IB466c | spoIIAC sspG::sspG-lacZ Cmr | IB464→SC1159 |
IB467c | spoIIGB sspG::sspG-lacZ Cmr Emre | IB464→SC137 |
IB468c | spoIIIG sspG::sspG-lacZ Cmr | IB464→SC500 |
IB469c | spoIVCB sspG::sspG-lacZ Cmr Emr | IB464→SC64 |
IB470c | sspG::sspG-lacZ Cmr | IB464→PY79 |
IB471c | spoIIAC sspJ::sspJ-lacZ Cmr | IB465→SC1159 |
IB472c | spoIIGB sspJ::sspJ-lacZ Cmr Emr | IB465→SC137 |
IB473c | spoIIIG sspJ::sspJ-lacZ Cmr | IB465→SC500 |
IB474c | spoIVCB sspJ::sspJ-lacZ Cmr Emr | IB465→SC64 |
IB475c | sspJ::sspJ-lacZ Cmr | IB465→PY79 |
IB502c | sspG::sspG-lacZ pspac-sigK sigKΔ19 Cmr Spr | IB470→BZ536 |
IB480c | sspJ::sspJ-lacZ spoIIIG [pSDA4] Cmr Kmrf | pSDA4→IB473 |
IB481c | sspJ::sspJ-lacZ spoIIIG [pDG298] Cmr Kmr | pDG298→IB473 |
IB492g | sspG::sspG-lacZ trpC2 Cmr | IB464→SG38 |
IB494g | gerE36 sspG::sspG-lacZ trpC2 Cmr | IB464→522.2 |
IB498g | SpβcotA-lacZ trpC2 Cmr Emr | Spβ::cotA-lacZ→SG38 |
IB511a | ΔsspG-yurS::spcΔ sspA ΔsspB ΔsspE Cmr Spr | IB488→PS482 |
IB515a | ΔsspJ::spc ΔsspA ΔsspB ΔsspE Cmr Spr | IB490→PS482 |
SC64c | spoIVCB Emr | S. Cutting |
SC137c | spoIIGB Emr | S. Cutting |
SC500c | spoIIIGΔ1 | S. Cutting |
SC1159c | spoIIAC1 | S. Cutting |
BZ536c | Pspac-PsigK sigKΔ19 Spr | L. Kroos |
522.2g | gerE36 trpC2 | L. Kroos |
SG38g | trpC2 | J. Errington |
Genetic background is PS832.
Cmr, chloramphenicol (5 μg/ml) resistance.
Genetic background is PY79.
Spr, spectinomycin (100 μg/ml) resistance.
Emr, erythromycin (1 μg/ml) resistance.
Kmr, kanamycin (10 μg/ml) resistance.
Derivatives of B. subtilis strain CU267 (originally obtained from S. A. Zahler).